Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 2/20 | 0.56 |
| ▸ | CES1 | P23141 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 5/20 | 0.55 |
| ▸ | CA2 | P00918 | 5/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | PDE4A | P27815 | 2/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.53 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5700298 | 0.98 | ALDH1A1 (0.63) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL10473228 | 0.86 | MAOB (0.56) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL10473229 | 0.86 | MAOB (0.56) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL9815845 | 0.85 | ALDH1A1 (0.65) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL8270539 | 0.84 | PDE4A (0.78) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL23259346 | 0.83 | ALDH1A1 (0.63) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL8271268 | 0.81 | ALDH1A1 (0.61) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL8994712 | 0.81 | MAPT (0.61) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL10683509 | 0.81 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTHPGDCES2 | |
| SCHEMBL10683513 | 0.81 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTHPGDCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10330603-B1 | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents | VERITEQUE USA, INC. | 2019-06-25 | — | — | US | claimed |
| US-11329229-B2 | Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices | KAUNO TECHNOLOGIES UNIVERSITETAS (LT) | 2022-05-10 | — | — | US | disclosed |
| US-11225480-B2 | Malic enzyme inhibitors | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-01-18 | — | — | US | disclosed |
| US-20210115038-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2021-04-22 | — | — | US | disclosed |
| US-10330603-B1 | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents | VERITEQUE USA, INC. | 2019-06-25 | — | — | US | disclosed |
| WO-2018051278-A2 | HOLE TRANSPORTING ORGANIC MOLECULES CONTAINING ENAMINE GROUPS FOR OPTOELECTRONIC AND PHOTOELECTROCHEMICAL DEVICES | Kauno technologijos universitetas (LT) | 2018-03-22 | — | — | WO | disclosed |
| US-20170213652-A1 | NOVEL SYNTHONS FOR DEVELOPING ORGANIC SEMICONDUCTORS | UNIVERSITÉ DE TOURS (FR) | 2017-07-27 | — | — | US | disclosed |
| US-20170213652-A1 | NOVEL SYNTHONS FOR DEVELOPING ORGANIC SEMICONDUCTORS | UNIVERSITÉ DE TOURS (FR) | 2017-07-27 | — | — | US | disclosed |
| WO-2016016221-A1 | NOVEL SYNTHONS FOR DEVELOPING ORGANIC SEMICONDUCTORS | UNIVERSITE DE TOURS FRANCOIS-RABELAIS (FR) | 2016-02-04 | — | — | WO | disclosed |
| US-7262294-B2 | Photochromatic pyrano-1,3-oxazinonaphthalene derivatives | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2007-08-28 | — | — | US | disclosed |
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| US-4770973-A | READABLE BY OPTICAL DEVICES AND FIXED BY LIGHT | Kanzaki Paper Manufacturing Limited (JP) | 1988-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | ALDH1A1 2369/4885KDM4E 381/4885MAPT 4856/4885 |
| US-20210115038-A1 | MALIC ENZYME INHIBITORS | ME1, ME2, ME3 | ALDH1A1 144/4885KDM4E 1301/4885MAPT 2817/4885 |
| US-11225480-B2 | Malic enzyme inhibitors | ME1, RNASE1, ME2 | ALDH1A1 89/4885KDM4E 821/4885MAPT 3825/4885 |
| US-11329229-B2 | Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices | OCIAD1, OCIAD2, SLCO4C1 | ALDH1A1 594/4885KDM4E 4217/4885MAPT 1504/4885 |
| US-20170213652-A1 | NOVEL SYNTHONS FOR DEVELOPING ORGANIC SEMICONDUCTORS | NES, NCL, CDK6 | ALDH1A1 4288/4885KDM4E 3992/4885MAPT 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.